Читать книгу Recent Advances in Dialysis Therapy in Japan - Группа авторов - Страница 17

1Tomo M, Iwasita T, Monda J: Possibility of protection of kidney function in PD-HD combination therapy (in Japanese). J Jpn Soc Dial Ther 2007;40:470–474.

2Popovich RP, Moncriff JW, Decherd JF: The definition of a novel portable/wearable equilibrium peritoneal dialysis technique. Trans Am Soc Artif Intern Organs 1976;5:64.

3Li PK, Szeto CC, Piraino B, Bernardini J, Figueiredo AE, Gupta A, Johnson DW, Kuijper EJ, Lye WC, Salzer W, Schaefer F, Struijk DG; International Society for Peritoneal Dialysis: Peritoneal dialysis-related infections recommendations: 2010 update. Perit Dial Int 2010;30:393–423.

4Nakamoto H: Proper dialysis, peritoneal dialysis, prognosis and prognostic factors (in Japanese). J Clin Exp Med 2011;239:752–759.

5Higuchi C, Tanihata Y, Nishimura H: Effects of glucose and plasminogen activator inhibitor-1 on collagen metabolism in the peritoneum. Ther Apher Dial 2005;9:173–181.

6Sennfält K, Magnusson M, Carlsson P: Comparison of hemodialysis and peritoneal dialysis – a cost-utility analysis. Perit Dial Int 2002;22:39–47.

7Takakura T: Evaluation as peritoneal dialysis home therapy – from the viewpoint of medical economy (in Japanese). J Jpn Soc Dial Ther 2012;28:15–24.

8Haller M, Gutjahr G, Kramar R, Harnoncourt F, Oberbauer R: Cost-effectiveness analysis of renal replacement therapy in Austria. Nephrol Dial Transplant 2011;26:2988–2995.

9Nakayama M, Ishida M, Ogihara M, Hanaoka K, Tamura M, Kanai H, Tonozuka Y, Marshall MR: Social functioning and socioeconomic changes after introduction of regular dialysis treatment and impact of dialysis modality: a multi-centre survey of Japanese patients. Nephrology (Carlton) 2015;20:523–530.

10Kobayashi T, Shirasaki F, Tomori K, Nagata M, Kita H, Okada K, Nakamoto H: Verification of the effect of icodextrin pH on peritoneal inflammation and fibrosis. Kidney Dial 2017;83(separate volume peritoneal dialysis 2017):206–207.

11Zhou Q, Bajo MA, Del Peso G, Yu X, Selgas R: Preventing peritoneal membrane fibrosis in peritoneal dialysis patients. Kidney Int 2016;90:515–524.

12Honda K: Peritoneal permeability of PD from pathology (in Japanese). Jpn J Soc Pediatr Nephrol 2013;26:20–26.

13Kobayashi T, Kouzaki H, Kita H: Human eosinophils recognize endogenous danger signal crystalline uric acid and produce proinflammatory cytokines mediated by autocrine ATP. J Immunol 2010;184:6350–6358.

14Kobayashi T, Soma T, Noguchi T, Nakagome K, Nakamoto H, Kita H, Nagata M: ATP drives eosinophil effector responses through P2 purinergic receptors. Allergol Int 2015;64(suppl):30–36.

15Trivedi SG, Lloyd CM: Eosinophils in the pathogenesis of allergic airways disease. Cell Mol Life Sci 2007;64:1269–1289.

16Hammad H, Lambrecht BN: Dendritic cells and epithelial cells: linking innate and adaptive immunity in asthma. Nat Rev Immunol 2008;8:193–204.

17Sonnenberg GF, Artis D: Innate lymphoid cells in the initiation, regulation and resolution of inflammation. Nat Med 2015;21:698–708.

18Cortez VS, Robinette ML, Colonna M: Innate lymphoid cells: new insights into function and development. Curr Opin lmmunol 2015;20:71–77.

19Walker JA, Barlow JL, McKenzie AN: Innate lymphoid cells – how did we miss them? Nat Rev Immunol 2013;13:75–87.

20Bartemes KR, Kephart GM, Fox SJ, Kita H: Enhanced innate type 2 immune response in peripheral blood from patients with asthma. J Allergy Clin Immunol 2014;134:671–678.

21Rock KL, Lai JJ, Kono H: Innate and adaptive immune responses to cell death. Immunol Rev 2011;243:191–205.

22Hara K, Iijima K, Elias MK, Seno S, Tojima I, Kobayashi T, Kephart GM, Kurabayashi M, Kita H: Airway uric acid is a sensor of inhaled protease allergens and initiates type 2 immune responses in respiratory mucosa. J Immunol 2014;192:4032–4042.

23Chen GY, Nuñez G: Sterile inflammation: sensing and reacting to damage. Nat Rev Immunol 2010;10:826–837.

24Touré F, Lavaud S, Mohajer M, Lavaud F, Canivet E, Nguyen P, Chanard J, Rieu P: Icodextrin-induced peritonitis: study of five cases and comparison with bacterial peritonitis. Kidney Int 2004;65:654–660.

25Topley N, Coles GA, Williams JD: Biocompatibility studies on peritoneal cells. Perit Dial Int 1994;14(suppl 3):S21–S28.

Takehito Kobayashi, MD, PhD

Department of General Internal Medicine, Saitama Medical University

38 Morohongo Moroyama-machi Iruma-gun

Saitama 350-0495 (Japan)

E-Mail kobatake@saitama-med.ac.jp